-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at the 2025 European International Nutrition and Health Food Exhibition
Category:
发布时间：2025-05-21
【概要描述】
On May 20, 2025, local time in Spain, the largest specialized trade show for the European nutrition and health supplement industry—the 2025 Vitafoods Europe—was held in Barcelona. As a leading Chinese pharmaceutical company accelerating its global expansion, Shijiazhuang Sihua Pharmaceutical Group showcased key products such as caffeine-based food additives and specialty active pharmaceutical ingredients at the event, highlighting the company’s competitive advantages in the raw-materials sector to international clients.
On May 20, 2025, local time in Spain, the largest specialized trade show for the European nutrition and health supplement industry—the 2025 Vitafoods Europe—was held in Barcelona. As a leading Chinese pharmaceutical company accelerating its global expansion, Shijiazhuang Sihua Pharmaceutical Group showcased key products such as caffeine-based food additives and distinctive active pharmaceutical ingredients at the event, highlighting the company’s strengths in the development of its raw-materials business to international clients.
According to reports, after 27 years of development, Vitafoods Europe has established a comprehensive, end-to-end platform for market expansion and technological exchange, bringing together leading companies in the health supplements, functional foods, and functional beverages sectors that specialize in raw materials, ingredients, finished products, manufacturing technologies, and consulting services.
“We must accelerate the Group’s ‘going global’ initiative, strengthen our overall capabilities in international operations, and continuously enhance our influence in the European market,” said a representative from the Group’s API Foreign Trade Center. “To this end, we will leverage the Vitafoods Europe exhibition as an excellent platform for connecting suppliers and buyers, fully showcase our corporate image, stay abreast of industry trends and developments, further deepen cooperation with our European partners, actively explore new business collaboration opportunities, and continually expand the availability of our API products across Europe.”
During the exhibition, the Group’s flagship caffeine raw material—boasting high purity and full traceability—attracted significant attention from food industry buyers and professionals in attendance. As one of the world’s leading suppliers of caffeine raw materials, the Group has continuously refined its production processes in recent years, achieving end-to-end green management across the entire value chain for caffeine production. In 2024, it obtained internationally recognized Product Carbon Footprint certification and has since secured numerous other prestigious international certifications and passed quality audits in multiple countries. Today, its key products, including caffeine, are exported to more than 60 countries and regions, further enhancing its competitiveness and influence in the global market.
“The European market exhibits substantial demand for functional food ingredients, while imposing exceptionally stringent quality requirements on active pharmaceutical ingredients. This places higher demands on us to accelerate our ‘going global’ strategy. Moving forward, we will focus on the cutting edge of the international raw-materials market, seize opportunities to expand our product exports, and elevate the Group’s international operations to a new level,” said a spokesperson from the Group’s API Foreign Trade Center.
Right from the start of the exhibition, the Group engaged in pragmatic discussions with numerous existing and new international clients, preliminarily reaching several intentions for business cooperation.
In recent years, Shijiazhuang Sihua Pharmaceutical Group has consistently regarded internationalization as its core strategy, actively engaging in global business exchanges and exhibiting at major international trade shows across Europe, the Americas, Asia, and Africa for many consecutive years. This year alone, the company has participated in five such events, striving to establish long-term, stable partnerships with customers worldwide.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091